ImmunoGen Inc (IMGN.OQ) News|
United States

ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

24 Jun 2016
Change (% chg)

$-0.19 (-5.72%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Wed, Jun 15 2016

BRIEF-ImmunoGen announces pricing of $100 mln offering of Senior Notes

* Sale of notes is expected to result in $96.7 million net proceeds to Immunogen

BRIEF-Immunogen announces proposed $100 mln offering of convertible senior notes

* Immunogen announces proposed $100 million offering of convertible senior notes due 2021

BRIEF-ImmunoGen reports positive early-stage data on ovarian cancer drug

* Reports efficacy and safety data from a 46 patient cohort of mirvetuximab soravtansine in fr-positive ovarian cancer

BRIEF-ImmunoGen Inc Q3 loss per share $0.37

* Immunogen Inc reports third quarter fiscal year 2016 financial results and provides corporate update

BRIEF-Immunogen appoints Mark Enyedy to newly-expanded board

* Board has voted to expand size of board from nine to ten members, and appointed Mark Enyedy to fill newly-created vacancy - SEC filing Source text for Eikon: [( )] Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

BRIEF-ImmunoGen appoints Mark Enyedy as president and CEO

* Immunogen appoints Mark Enyedy as president and chief executive officer

Select another date: